Cumulatively, these findings demonstrate that HNF1A-AS1 is a key regulator in bladder cancer progression, which highlights its potential clinical utility as a promising prognostic and therapeutic target of bladder cancer. The gene discussed is HNF1A; the disease is urinary bladder carcinoma.